Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer
Clinical trial NCT02010567 · TERMINATED
Trial details
- NCT number
- NCT02010567
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2016-09-16
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.